scispace - formally typeset
D

Daniel C. Malone

Researcher at University of Arizona

Publications -  279
Citations -  9359

Daniel C. Malone is an academic researcher from University of Arizona. The author has contributed to research in topics: Health care & Medicine. The author has an hindex of 45, co-authored 236 publications receiving 8326 citations. Previous affiliations of Daniel C. Malone include University of Iowa & University of Colorado Denver.

Papers
More filters
Journal ArticleDOI

Measurement of Adherence in Pharmacy Administrative Databases: A Proposal for Standard Definitions and Preferred Measures

TL;DR: Five measures of calculating refill adherence from administrative data are compared and MRA is recommended as the preferred measure of adherence using administrative data because it has the fewest calculations, is easily truncated if one desires to exclude surplus medication issues, and requires the least amount of data.
Journal ArticleDOI

A National Estimate of the Economic Costs of Asthma

TL;DR: Findings from this study indicate that future asthma research and intervention efforts directed at hospitalizations and high-cost patients could help to decrease health care resource use and provide cost savings.
Journal ArticleDOI

Excessive Antibiotic Use for Acute Respiratory Infections in the United States

TL;DR: The amount and cost of excessive antibiotic use for acute respiratory infections by primary care physicians are substantial and potential target rates for antibiotic treatment of selected conditions are established.
Journal ArticleDOI

A cost of illness study of allergic rhinitis in the United States

TL;DR: Allergic rhinitis clearly creates a burden in terms of the number of persons affected, total expenditures, and lost productivity, and it also appears that a relatively large proportion of persons with allergic Rhinitis were not seeking medical treatment.
Journal ArticleDOI

Health services use and health care costs of obese and nonobese individuals.

TL;DR: Over 1 year, health care costs for obese persons are higher than for nonobese persons, primarily because of prescription drugs.